ArticleAnnals of gastroenterological surgery2026
Survival Outcomes of Gemcitabine-Cisplatin-S-1 Versus Gemcitabine-Cisplatin in Unresectable Biliary Tract Cancer: A Multicenter Retrospective Study With a Focus on Conversion Surgery.
Hisashi Kosaka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.